Cisplatin resistance by induction of aldoketo reductase family 1 member C2 in human bladder cancer cells

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.7, Iss.3, 2014-01, pp. : 674-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 184-196

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 91-98

Spandidos Publications

Access to resources Recommend Favorite

Aldo-Keto Reductase Family 1 Member B1 Inhibitors: Old Drugs with New Perspectives

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 246-253

Bentham Science Publishers

Access to resources Recommend Favorite

p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2341-2348

Spandidos Publications

Access to resources Recommend Favorite

Enforced expression of miR101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase2 pathway

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 2203-2209

Spandidos Publications

Access to resources Recommend Favorite